185 related articles for article (PubMed ID: 17309824)
21. Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions.
Tesselaar K; Arens R; van Schijndel GM; Baars PA; van der Valk MA; Borst J; van Oers MH; van Lier RA
Nat Immunol; 2003 Jan; 4(1):49-54. PubMed ID: 12469117
[TBL] [Abstract][Full Text] [Related]
22. Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells.
Dai Y; Chen S; Kramer LB; Funk VL; Dent P; Grant S
Clin Cancer Res; 2008 Jan; 14(2):549-58. PubMed ID: 18223231
[TBL] [Abstract][Full Text] [Related]
23. CD27 and CD70 in T cell and B cell activation.
Borst J; Hendriks J; Xiao Y
Curr Opin Immunol; 2005 Jun; 17(3):275-81. PubMed ID: 15886117
[TBL] [Abstract][Full Text] [Related]
24. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
[TBL] [Abstract][Full Text] [Related]
25. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology.
Nolte MA; van Olffen RW; van Gisbergen KP; van Lier RA
Immunol Rev; 2009 May; 229(1):216-31. PubMed ID: 19426224
[TBL] [Abstract][Full Text] [Related]
26. Induction of CD95 upregulation does not render chronic lymphocytic leukemia B-cells susceptible to CD95-mediated apoptosis.
Romano C; De Fanis U; Sellitto A; Chiurazzi F; Guastafierro S; Giunta R; Tirelli A; Rotoli B; Lucivero G
Immunol Lett; 2005 Feb; 97(1):131-9. PubMed ID: 15626485
[TBL] [Abstract][Full Text] [Related]
27. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase-8 is overexpressed in Waldenström's macroglobulinemia cells, and specific inhibition of this metalloproteinase blocks release of soluble CD27.
Zhou Y; Liu X; Xu L; Tseng H; Cao Y; Jiang J; Ciccarelli BT; Yang G; Patterson CJ; Hunter ZR; Treon SP
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):172-5. PubMed ID: 21856553
[TBL] [Abstract][Full Text] [Related]
29. Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia.
Eisele L; Haddad T; Sellmann L; Dührsen U; Dürig J
Leuk Res; 2009 Jun; 33(6):775-8. PubMed ID: 18922578
[TBL] [Abstract][Full Text] [Related]
30. Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation.
Bourlier V; Zakaroff-Girard A; De Barros S; Pizzacalla C; de Saint Front VD; Lafontan M; Bouloumié A; Galitzky J
J Pharmacol Exp Ther; 2005 Mar; 312(3):1272-9. PubMed ID: 15537822
[TBL] [Abstract][Full Text] [Related]
31. High functional CD70 expression on α-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia.
Junevik K; Werlenius O; Fogelstrand L; Karlsson-Parra A; Andersson PO
Scand J Immunol; 2014 Jun; 79(6):415-22. PubMed ID: 24684541
[TBL] [Abstract][Full Text] [Related]
32. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
33. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
34. Vaccine- and immune-based therapy in chronic lymphocytic leukemia.
Le Dieu R; Gribben J
Semin Oncol; 2006 Apr; 33(2):220-9. PubMed ID: 16616069
[TBL] [Abstract][Full Text] [Related]
35. The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans.
Hashimoto-Okada M; Kitawaki T; Kadowaki N; Iwata S; Morimoto C; Hori T; Uchiyama T
Int Immunol; 2009 Aug; 21(8):891-904. PubMed ID: 19556308
[TBL] [Abstract][Full Text] [Related]
36. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
37. Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.
Rodriguez JM; Elias F; Montaner A; Flo J; Lopez RA; Zorzopulos J; Franco RJ; Lenial SP; Lopez Salón M; Pirpignani ML; Solimano J; Garay G; Riveros D; Fernandez J; Cacchione R; Dupont J
Medicina (B Aires); 2006; 66(1):9-16. PubMed ID: 16555722
[TBL] [Abstract][Full Text] [Related]
38. Immune activation modulates hematopoiesis through interactions between CD27 and CD70.
Nolte MA; Arens R; van Os R; van Oosterwijk M; Hooibrink B; van Lier RA; van Oers MH
Nat Immunol; 2005 Apr; 6(4):412-8. PubMed ID: 15723067
[TBL] [Abstract][Full Text] [Related]
39. The cloning of CD70 and its identification as the ligand for CD27.
Bowman MR; Crimmins MA; Yetz-Aldape J; Kriz R; Kelleher K; Herrmann S
J Immunol; 1994 Feb; 152(4):1756-61. PubMed ID: 8120384
[TBL] [Abstract][Full Text] [Related]
40. Signalling via CD70, a member of the TNF family, regulates T cell functions.
García P; De Heredia AB; Bellón T; Carpio E; Llano M; Caparrós E; Aparicio P; López-Botet M
J Leukoc Biol; 2004 Jul; 76(1):263-70. PubMed ID: 15226368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
